Sanjay J Mathew

Title: Sanjay J Mathew: Innovator in Depression Treatment

Introduction

Sanjay J Mathew is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of mental health, particularly in the treatment of depression. With a total of 3 patents, his work focuses on innovative methods to address treatment-resistant depression.

Latest Patents

One of his latest patents involves the intranasal administration of ketamine to treat depression. This invention describes methods and compositions that demonstrate the effectiveness of intranasal ketamine in ameliorating symptoms of depression in patients who have not responded to an adequate trial of one antidepressant during their current episode. This is particularly relevant for individuals with recurrent or chronic depressive symptoms lasting more than two years. Another patent focuses on methods for treating suicidal ideation, again utilizing intranasal ketamine to provide relief for those suffering from treatment-resistant depression.

Career Highlights

Sanjay J Mathew has held positions at prestigious institutions such as the Icahn School of Medicine at Mount Sinai and Yale University. His work in these environments has allowed him to collaborate with leading experts in the field of psychiatry and mental health.

Collaborations

Some of his notable coworkers include Dennis S Charney and Husseini K Manji. Their collective expertise has contributed to advancing research and treatment options for depression.

Conclusion

Sanjay J Mathew's innovative approaches to treating depression highlight the importance of continued research and development in mental health. His contributions are paving the way for more effective treatments for those who struggle with this challenging condition.